An anatomical basis for opponent process mechanisms of opiate withdrawal

Journal of Neuroscience

Volumn 31, Issue 20, 2011, Pages 7533-7539

  Radke, Anna K ^a   Rothwell, Patrick E ^a,b   Gewirtz, Jonathan C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; MORPHINE; NALOXONE; OPIATE; OPIATE RECEPTOR;

ANATOMICAL VARIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR THEORY; BRAIN FUNCTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; LOCOMOTION; MALE; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RAT; STARTLE REFLEX; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME;

ANIMALS; MALE; MOTOR ACTIVITY; NERVE NET; OPIOID-RELATED DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SENSORY GATING; SUBSTANCE WITHDRAWAL SYNDROME; VENTRAL TEGMENTAL AREA;

EID: 79956298602     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0172-11.2011     Document Type: Article

References (65)

1. Acquas E, Di Chiara G (1992) Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J Neurochem 58:1620-1625.
2. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC (2004) Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 111:33-51.
3. Bechara A, Nader K, van der Kooy D (1995) Neurobiology of withdrawal motivation: evidence for two separate aversive effects produced in morphine-naïve vs. morphine-dependent rats by both naloxone and spontaneous withdrawal. Behav Neurosci 109:91-105.
4. Bergstrom DA, Bromley SD, Walters JR (1982) Apomorphine increases the activity of rat globus pallidus neurons. Brain Res 238:266-271.
5. Bozarth MA, Wise RA (1984) Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224:516-517.
6. Broekkamp CL, Phillips AG (1979) Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area. Pharmacol Biochem Behav 11:289-295.
7. Cabral A, Ruggiero RN, Nobre MJ, Brandão ML, Castilho VM (2009) GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine. Prog Neuropsychopharmacol Biol Psychiatry 33:334-344.
8. Caillé S, Rodriguez-Arias M, Minarro J, Espejo EF, Cador M, Stinus L (2003) Changes in dopaminergic neurotransmission do not alter somatic or motivational opiate withdrawal-induced symptoms in rats. Behav Neurosci 117:995-1005.
9. Carboni E, Silvagni A, Rolando MT, Di Chiara G (2000) Stimulation of in vivo dopamine transmission in the bed nucleus of the stria terminalis by reinforcing drugs. J Neurosci 20: RC102.
10. Carlson JH, Bergstrom DA, Walters JR (1987) Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study. Brain Res 400:205-218.
11. Chartoff EH, Mague SD, Barhight MF, Smith AM, Carlezon WA Jr (2006) Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J Neurosci 26: 6450-6547.
12. Davis M, Walker DL, Miles L, Grillon C (2010) Phasic vs. sustained fear in rats and humans: role of the extended amygdala in fear vs. anxiety. Neuropsychopharmacology 35:105-135.
13. Day HE, Vittoz NM, Oates MM, Badiani A, Watson SJ Jr, Robinson TE, Akil H (2002) A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Brain Res 945:151-159.
14. de Olmos JS, Heimer L (1999) The concepts of the ventral striatopallidal system and extended amygdala. Ann NY Acad Sci 877:1-32.
15. Diana M, Pistis M, Muntoni A, Gessa G (1995) Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J Pharmacol Exp Ther 272:781-785.
16. Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL (1999) Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur J Neurosci 11:1037-1041.
17. Fallon JH, Koziell DA, Moore RY (1978) Catacholamine innervation of the basal forebrain: II. Amygdala, suprarhinal cortex, and entorhinal cortex. J Comp Neur 180:509-532.
18. Fenu S, Spina L, Rivas E, Logoni R, Di Chiara G (2006) Morphineconditioned single trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression. Psychopharmacology (Berl) 187:143-153.
19. Frenois F, Cador M, Caillé S, Stinus L, Le Moine C (2002) Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16:1377-1389.
20. Geisler S, Derst C, Veh RW, Zahm DS (2007) Glutamatergic afferents of the ventral tegmental area in the rat. J Neurosci 27:5730-5743.
21. Georges F, Aston-Jones G (2003) Prolonged activation of mesolimbic dopamine neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors. Neuropsychopharmacology 28:1140-1149.
22. Georges F, Le Moine C, Aston-Jones G (2006) No effect of morphine on ventral tegmental dopamine neurons during withdrawal. J Neurosci 26:5720-5726.
23. Guiard BP, El Mansari M, Blier P (2008) Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus. Mol Pharmacol 74:1463-1475.
24. Gutman AR, Yang Y, Ressler KJ, Davis M (2008) The role of neuropeptide Y in the expression and extinction of conditioned fear. J Neurosci 28:12682-12690.
25. Harris AC, Gewirtz JC (2004) Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety. Psychopharmacology (Berl) 171:140-147.
26. Harris AC, Atkinson DM, Aase DM, Gewirtz JC (2006) Double dissociation in the neural substrates of acute opiate dependence as measured by withdrawal-potentiated startle. Neuroscience 139:1201-1210.
27. Harris GC, Aston-Jones G (1994) Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371:155-157.
28. Hasue RH, Shammah-Lagnado SJ (2002) Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a retrograde and immunohistochemical study in the rat. J Comp Neurol 454: 15-33.
29. Herman JP, Guillonneau D, Dantzer R, Scatton B, Semerdjian-Rouquier L, Le Moal M (1982) Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. Life Sciences 30:2207-2214.
30. Higgins GA, Sellers EM (1994) Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharmacol Biochem Behav 48:1-8.
31. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488.
32. Kalinichev M, Holtzman SG (2003) Changes in urination/defecation, auditory startle response, and startle-induced vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence. J Pharmacol Exp Ther 304:603-609.
33. Kash TL, Nobis WP, Matthews RT, Winder DG (2008) Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1 dependent process. J Neurosci 28:13856-13865.
34. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
35. Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52-58.
36. Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191.
37. Laviolette SR, Nader K, van der Kooy D (2002) Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res 129:17-29.
38. Leaton RN, Borszcz GS (1985) Potentiated startle: its relation to freezing and shock intensity in rats. J Exp Psychol 11:421-428.
39. Leone P, Pocock D, Wise RA (1991) Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav 39:469-472.
40. Liu ZH, Shin R, Ikemoto S (2008) Dual role of medial A10 dopamine neurons in affective encoding. Neuropsychopharmacology 33:3010-3020.
41. Maldonado R, Stinus L, Gold LH, Koob GF (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669-677.
42. Meloni EG, Gerety LP, Knoll AT, Cohen BM, Carlezon WA Jr (2006) Behavioral and anatomical interactions between dopamine and corticotropinreleasing factor in the rat. J Neurosci 26:3855-3863.
43. Nakagawa T, Yamamoto R, Fujio M, Suzuki Y, Minami M, Satoh M, Kaneko S (2005) Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience 134:9-19.
44. Nestler EJ, Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiat 59:1151-1159.
45. Oakman SA, Faris PL, Kerr PE, Cozzari C, Hartman BK (1995) Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 15:5859-5869.
46. Olmstead MC, Franklin KB (1997) The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behav Neurosci 111:1324-1334.
47. Pan WX, Hyland BI (2005) Pedunculopontine tegmental nucleus controls conditioned responses of midbrain dopamine neurons in behaving rats. J Neurosci 25:4725-4732.
48. Pezze MA, Feldon J (2004) Mesolimbic dopamine pathways in fear conditioning. Prog Neurobiol 74:301-320.
49. Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54:25-53.
50. Rodríguez-Arias M, Pinazo J, Miñarro J, Stinus L (1999) Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice. Pharmacol Biochem Behav 64:123-130.
51. Rosenkranz JA, Grace AA (1999) Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J Neurosci 19:11027-11039.
52. Rossetti ZL, Hmaidan Y, Gessa GL (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine, and amphetamine abstinence in rats. Eur J Pharmacol 221:227-234.
53. Rothwell PE, Thomas MJ, Gewirtz JC (2009) Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure. Neuropsychopharmacology 34:2285-2295.
54. Rothwell PE, Gewirtz JC, Thomas MJ (2010) Episodic withdrawal promotes psychomotor sensitization to morphine. Neuropsychopharmacology 35:2579-2589.
55. Shaham Y, Kelsey JE, Stewart J (1995) Temporal factors in the effect of restraint stress on morphine-induced behavioral sensitization in the rat. Psychopharmacology (Berl) 117:102-109.
56. Smiałowska M, Bajkowska M, Prezewł ocka B, Maj M, Turchan J, Przewł ocki R (1999) Effect of 6-hydroxydopamine on neuropeptide Y and corticotropin-releasing factor expression in rat amygdala. Neuroscience 94:1125-1132.
57. Smith RJ, Aston-Jones G (2008) Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct 213:43-61.
58. Solomon RL, Corbit JD (1974) An opponent process theory of motivation. Psychol Rev 81:119-145.
59. Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A 89:2046-2050.
60. Stewart J, Horton C, Robinson B, Amir S (2008) Unilateral loss of dopaminergic innervation suppresses the expression of CRF-IR in the ipsilateral oval nucleus of the bed nucleus of the stria terminalis and central nucleus of the amygdala in the rat. Soc Neurosci Abstr 34:767.21.
61. Stinus L, Le Moal M, Koob GF (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767-773.
62. Vargas-Perez H, Ting-A-Kee RA, Heinmiller A, Sturgess JE, van der Kooy D (2007) A test of the opponent process theory of motivation using lesions that selectively block morphine reward. Eur J Neurosci 25:3713-3718.
63. Vargas-Perez H, Ting-A-Kee R, van der Kooy D (2009) Different neural systems mediate morphine reward and its spontaneous withdrawal aversion. Eur J Neurosci 29:2029-2034.
64. Vezina P, Stewart J (1984) Conditioned and place-specific sensitization of increases in activity induced by morphine in the VTA. Pharmacol Biochem Behav 20:925-934.
65. Wise RA, Leone P, Rivest R, Leeb K (1995) Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin selfadministration. Synapse 21:140-148.